Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare EPO Proposal Would Withdraw Or Limit Coverage For Certain Cancer Uses

This article was originally published in The Pink Sheet Daily

Executive Summary

National Medicare coverage analysis follows recent FDA advisory committee review.

You may also be interested in...



ASCO Updates ESA Treatment Guidelines

Recommendation made jointly with American Society of Hematology calls for maintaining hemoglobin levels above 10 g/dL.

ASCO Updates ESA Treatment Guidelines

Recommendation made jointly with American Society of Hematology calls for maintaining hemoglobin levels above 10 g/dL.

EPO Use OK In All But Eight Cancer Conditions, Medicare NCD Says

Final National Coverage Determination issued July 30 drops number of restricted uses of erythropoiesis-stimulating agents from the 13 listed in the draft NCD.

Related Content

Topics

UsernamePublicRestriction

Register

PS066029

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel